These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 14285481)

  • 21. [ANTI-SEROTONIN ACTION AND OTHER PHARMACOLOGICAL EFFECTS OF SOME ANALOGUES OF NATURAL ERGOT ALKALOIDS].
    VOTAVA Z; LAMPLOVA I
    Therapie; 1964; 19():733-42. PubMed ID: 14182956
    [No Abstract]   [Full Text] [Related]  

  • 22. [THE PROBLEM OF THERAPEUTIC SHOCK, PROPHYLAXIS AND TREATMENT OF THE LATTER].
    SALAZARMALLEN M
    Salud Publica Mex; 1964; 6():591-3. PubMed ID: 14196474
    [No Abstract]   [Full Text] [Related]  

  • 23. Experimental studies with the butanolamide and propanolamide of 1-methyl-lysergic acid.
    GELFAND MD; WEST GB
    Int Arch Allergy Appl Immunol; 1961; 18():286-91. PubMed ID: 13704268
    [No Abstract]   [Full Text] [Related]  

  • 24. Interactions between lysergic acid diethylamide and dopamine-sensitive adenylate cyclase systems in rat brain.
    Hungen KV; Roberts S; Hill DF
    Brain Res; 1975 Aug; 94(1):57-66. PubMed ID: 238721
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cross tolerance between D-2-brom-lysergic acid diethylamide (BOL-148) and the D-diethylamide of lysergic acid (LSD-25).
    ISBELL H; MINER EJ; LOGAN CR
    Psychopharmacologia; 1959 Nov; 1():109-16. PubMed ID: 14405871
    [No Abstract]   [Full Text] [Related]  

  • 26. Hyperthermic effects of D-lysergic acid diethylamide (LSD) and its derivatives in rabbits and rats.
    Hashimoto H; Hayashi M; Nakahara Y; Niwaguchi T; Ishii H
    Arch Int Pharmacodyn Ther; 1977 Aug; 228(2):314-21. PubMed ID: 303504
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [EFFECT OF LYSENYL, DESERIL AND OTHER SEROTONIN ANTAGONISTS ON BIOCHEMICAL SYSTEMS].
    RYSANEK K; VITEK V
    Act Nerv Super (Praha); 1963 May; 5():210-1. PubMed ID: 14070658
    [No Abstract]   [Full Text] [Related]  

  • 28. Stereoselective pharmacological effects of lysergic acid amides possessing chirality in the amide substituent.
    Nichols DE; Monte A; Huang X; Marona-Lewicka D
    Behav Brain Res; 1996; 73(1-2):117-9. PubMed ID: 8788487
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A FURTHER STUDY ON ALLEVIATION OF THE PSYCHOLOGICAL EFFECTS OF LSD IN MAN BY PRETREATMENT WITH 5-HYDROXYTRYPTOPHAN.
    PARE CM; LABROSSE EH
    J Psychiatr Res; 1963 Dec; 1():271-7. PubMed ID: 14101007
    [No Abstract]   [Full Text] [Related]  

  • 30. SEROTONIN BINDING TO NERVE-ENDING PARTICLES OF THE RAT BRAIN AND ITS INHIBITION BY LYSERGIC ACID DIETHYLAMIDE.
    MARCHBANKS RM; ROSENBLATT F; O'BRIEN RD
    Science; 1964 May; 144(3622):1135-6. PubMed ID: 14148433
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PROPHYLACTIC TREATMENT OF MIGRAINE BY MEANS OF LYSERGIC ACID DERIVATIVES.
    SICUTERI F
    Triangle; 1963 Oct; 6():116-25. PubMed ID: 14087164
    [No Abstract]   [Full Text] [Related]  

  • 32. [Clinical and rheographic considerations on a new antiserotonin derivative (UML-491) with preventive action in hemicrania].
    REBUCCI GG; COCCAGNA G
    Riv Neurol; 1962; 32():574-85. PubMed ID: 13973457
    [No Abstract]   [Full Text] [Related]  

  • 33. HISTOCHEMICAL STUDIES ON THE MECHANISM OF ACTION OF THE HALLUCINOGENS D-LYSERGIC ACID DIETHYLAMIDE TARTRATE (LSD-25) AND D-2-BROMO-LYSERGIC ACID TARTRATE (BOL-148) IN RAT BRAIN.
    SHANTHAVEERAPPA TR; NANDY K; BOURNE GH
    Acta Neuropathol; 1963 Sep; 3():29-39. PubMed ID: 14197655
    [No Abstract]   [Full Text] [Related]  

  • 34. D-LYSERGIC ACID DIETHYLAMIDE (LSD): A REVIEW OF ITS PRESENT STATUS.
    HOFFER A
    Clin Pharmacol Ther; 1965; 6():183-255. PubMed ID: 14288188
    [No Abstract]   [Full Text] [Related]  

  • 35. Blockade of depressor responses to serotonin and tryptamine by lysergic acid derivatives in the chicken.
    BUNAG RD; WALASZEK EJ
    Arch Int Pharmacodyn Ther; 1962 Jan; 135():142-51. PubMed ID: 13874645
    [No Abstract]   [Full Text] [Related]  

  • 36. Antagonism between an antiserotonin-the butanolamide of 1-methyl-lysergic acid--and the effects of a histamine-liberating substance 48/80 B. W. in man.
    SICUTERI F; MICHELACCI S; FRANCHI G
    Int Arch Allergy Appl Immunol; 1959; 15():291-9. PubMed ID: 14446403
    [No Abstract]   [Full Text] [Related]  

  • 37. The action of lysergic acid diethyl-amide on mammalian cholinesterases.
    THOMPSON RH; TICKNER A; WEBSTER GR
    Br J Pharmacol Chemother; 1955 Mar; 10(1):61-5. PubMed ID: 14351688
    [No Abstract]   [Full Text] [Related]  

  • 38. The anti-tumor action of lysergic acid derivatives and their serotonin-blocking effect as reflected by the I 131 distribution in rats.
    SCOTT KG; STONE RS
    Cancer Res; 1959 Aug; 19():783-7. PubMed ID: 14444248
    [No Abstract]   [Full Text] [Related]  

  • 39. Evaluation of UML-491 in the treatment of vascular headaches. An analysis of the effects of 1-methyl-D-lysergic acid (plus) butanolamide bimaleate (methysergide).
    FRIEDMAN AP; LOSIN S
    Arch Neurol; 1961 Mar; 4():241-5. PubMed ID: 13701987
    [No Abstract]   [Full Text] [Related]  

  • 40. FEATURES OF EXPERIMENTAL NEUROSIS PRODUCED BY LYSERGIC ACID DIETHYLAMINE.
    IVANOVA RA; LARICHEVA KA; MILSHTEIN GI
    Fed Proc Transl Suppl; 1964; 23():268-71. PubMed ID: 14145650
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.